Conditions: Glabellar Frown Lines
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 40
Healthy volunteers: no

Brief summary:
This was a pilot study to observe patient satisfaction with BOTOX® Cosmetic treatment in glabellar rhytides (frown lines) using a new treatment satisfaction measure.

Detailed description:

Arms:
arm 1: Botulinum toxin Type A 20U (total dose) injected into the glabellar region on Day 0. arm 2: Normal Saline (placebo) injected into the glabellar region on Day 0.

Interventions: intervention 1: botulinum toxin Type A intervention 2: normal saline (placebo)
Intervention descriptions: intervention 1: botulinum toxin Type A 20U (total dose) injected into the glabellar region on Day 0. intervention 2: Normal saline (placebo) injected into the glabellar region on Day 0.

Protocol document: